Vastarel MR Report for Patients Like You

What is Vastarel MR?

An example of Vastarel MR

Vastarel MR is a modified release formulation of trimetazidine, a cardiovascular agent used for long-term treatment of angina pectoris. It is an international product not available in the U.S.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
			Perceived Effectiveness
Purpose	# of patients	# of patients with evaluations	Major	Moderate	Slight	None	Can’t tell
Vertigo	1	0

See 1 patient currently taking Vastarel MR

Mouse over the table for more information

Reported Dosages

	70 mg daily
	1

Reported Stop Reasons

Why Patients Stopped Taking Vastarel MR (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Other	1

See all 1 patient who’ve stopped taking Vastarel MR

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Currently Taking Vastarel MR

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	0	0	1

Stopped Taking Vastarel MR

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	0	0	1